DISCOVER
User Support
User support
is available in both
French
and english
This service falls within the scope of the ISO 9001 quality management system. Under the applicable contractual conditions, it participates in the Service Level Agreement.
The service is provided by our operational teams (levels 1 and 2) and technical teams (level 3).
Access H24
via the WEB Portal
Please address your support requests via the WEB portal. You must have an access account.
Connexion
If you do not have an access account:
Request an access account
Email: hotline@tentelemed.com
Hotline
You can also access support via the hotline service.
Call number:
Unless it is specified in the contract, the hotline is available during business hours: 9.30 a.m. – 6 p.m. (Paris – GMT+1)
Remote call-out
Our hotliners have a commercial platform allowing, with the authorisation of the user, remote
Access requestto the “hotline” portal
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
2 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
November 30, 2023
📅 5th December – 1:30pm to 2:15pm (CET) 📍 On line via Gotowebinar 💶 Free but mandatory registration Register In Clinical Research, difficulties in recruiting subjects are one of the main causes of premature termination of clinical trials. Between 20 to 30% of clinical trials are affected by inclusion delays and more than 1 out of […]
November 30, 2023
Applied Clinical Trials Online Site and project management teams play major roles in risk-management and monitoring performance. As the modernization of clinical research through digital and decentralized solutions continues to take research into local communities, reduce patient and site burden, and increase diversity, it will lead to new ways of working for project delivery teams. […]
November 30, 2023
Applied Clinical Trials Online Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are. In a study published earlier this month by JAMA, the authors aimed to discover how the pharmaceutical industry gets involved in the most influential modern clinical trials and how they fare […]